Carmat SA
Carmat SA designs and develops total artificial heart for patients with advanced heart failure in France and internationally. The company offers Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.
Carmat SA (CXT) - Total Liabilities
Latest total liabilities as of December 2024: €93.56 Million EUR
Based on the latest financial reports, Carmat SA (CXT) has total liabilities worth €93.56 Million EUR as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Carmat SA - Total Liabilities Trend (2013–2024)
This chart illustrates how Carmat SA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Carmat SA Competitors by Total Liabilities
The table below lists competitors of Carmat SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Modern Healthcare Technology Holdings Limited
F:M3L
|
Germany | €362.05 Million |
|
Taoping Inc
NASDAQ:TAOP
|
USA | $15.84 Million |
|
Vaxxa AB
F:7WA0
|
Germany | €2.05 Million |
|
PFEIFFER VACU TECH
MU:PFV
|
Germany | €403.52 Million |
|
Adial Pharmaceuticals Inc
NASDAQ:ADIL
|
USA | $1.15 Million |
|
PROGRESSIVE (OHIO) - Dusseldorf Stock Exchang
DU:PGV
|
Germany | €78.04 Billion |
|
Novolog Pharm-Up 1966 Ltd
TA:NVLG
|
Israel | ILA2.68 Billion |
|
M N C Wireless Bhd
KLSE:0103
|
Malaysia | RM8.80 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Carmat SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.83 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Carmat SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Carmat SA (2013–2024)
The table below shows the annual total liabilities of Carmat SA from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €93.56 Million | -3.38% |
| 2023-12-31 | €96.83 Million | +16.29% |
| 2022-12-31 | €83.27 Million | +0.77% |
| 2021-12-31 | €82.63 Million | +24.21% |
| 2020-12-31 | €66.52 Million | +65.45% |
| 2019-12-31 | €40.21 Million | +37.01% |
| 2018-12-31 | €29.35 Million | +14.20% |
| 2017-12-31 | €25.70 Million | +18.66% |
| 2016-12-31 | €21.66 Million | +198.87% |
| 2015-12-31 | €7.25 Million | +15.43% |
| 2014-12-31 | €6.28 Million | -13.30% |
| 2013-12-31 | €7.24 Million | -- |